Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 203-366-1 | CAS number: 106-14-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Key value for chemical safety assessment
Additional information
The toxicokinetics of fatty acids such as 12-hydroxystearic acid and triglycerides such as those contained in hydrogenated castor oil and castor oil are well known due to their widespread use in nutritional (food and feed), cosmetic and industrial applications.
ORAL
Upon oral uptake, triglycerides are first broken down into fatty acids and monoglycerides which are absorbed by the cells forming the intestinal barrier (enterocytes). Free fatty acids are absorbed directly. Within the entrocytes, triglycerides are (re)built and packaged together with cholesterol and proteins to form chylomicrons. These are excreted by the enterocytes, collected by the lymph system and transported to the large vessels near the heart before entering the blood.Eventually, they bind to the membranes of hepatocytes, adipocytes or muscle fibers, where they are either stored or oxidized for energy.When the body requires fatty acids as a source of energy, the hormone glucagon signals the breakdown of the triglycerides by hormone-sensitive lipases to release free fatty acids. The fatty acids are then broken down by stepwise elimination of C2-units in the mitochondrial β-oxidation. Alternate oxidation pathways can be found in the liver (ω-oxidation) and the brain (α-oxidation) (HERA, 2002). The C2-units are esterified to acetyl-coenzyme A which directly enters the citric acid cycle where it is converted to carbon dioxide and energy (Binderet al., 1970; MacDonald, 1973; Robinson, 1973; Chen and Farese, 2002).
The extent of absorption in the gastro-intestinal system varies depending on the chain length of the fatty acids and their degree of saturation. Generally, short-chain fatty acids are better absorbed than the long chain counterparts. Also, absorption decreases with increasing saturation (MacDonald, 1973; Robinson, 1973; Chen and Farese, 2002).
Binder et al. (1970) fed rats with diets containing 1 or 10% hydrogenated castor oil (main constituent: 12-hydrostearic acid) for 4, 8, 12 and 16 weeks. The maximum content of 12-hydroxystearic acid was 4.4% in adipose tissues after 4 weeks on the 10% diet. When hydrogenated castor oil was replaced with corn oil, 12-hydroxystearic acid was depleted from the tissues. 10-hydroxypalmitic and 8-hydroxymyristic acids were characterised as metabolites.
In an overview by the Cosmetic Ingredient Review Panel (CIR, 1987), stearic acid, a close structural analogue of 12-hydroxystearic acid, was cited as being the most poorly absorbed of the common fatty acids.
DERMAL
No experimental studies were located for absorption through the dermal route. However, as per Section R.7.12.2.1 of REACH guidance document R7.C (May 2008), the extent of dermal absorption may be predicted based on physico-chemical properties, including:
- Water solubility
- Partition coefficient
12-hydroxystearic acid is poorly water soluble and has an estimated log Kow > 4. As such, uptake into thestratum corneum of skin and further transfer into the epidermis are likely to be limited. This is in accordance with data from a dermal penetration study in rats (Butcher, 1951) in which ricinoleic acid was shown to be retained mainly in the outer strata of the epidermis.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.